JP2009545549A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009545549A5 JP2009545549A5 JP2009522200A JP2009522200A JP2009545549A5 JP 2009545549 A5 JP2009545549 A5 JP 2009545549A5 JP 2009522200 A JP2009522200 A JP 2009522200A JP 2009522200 A JP2009522200 A JP 2009522200A JP 2009545549 A5 JP2009545549 A5 JP 2009545549A5
- Authority
- JP
- Japan
- Prior art keywords
- butyrate
- amino
- carbamoyl
- compound
- trimethylammonium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06118338 | 2006-08-02 | ||
| PCT/EP2007/057030 WO2008015081A1 (en) | 2006-08-02 | 2007-07-10 | Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009545549A JP2009545549A (ja) | 2009-12-24 |
| JP2009545549A5 true JP2009545549A5 (enExample) | 2010-09-02 |
Family
ID=37395789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009522200A Withdrawn JP2009545549A (ja) | 2006-08-02 | 2007-07-10 | Ｃｐｔ阻害剤としての４−トリメチルアンモニウム−３−アミノブチレートおよび４−トリメチルフォスフォニウム−３−アミノブチレート誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090312286A1 (enExample) |
| EP (1) | EP2046734A1 (enExample) |
| JP (1) | JP2009545549A (enExample) |
| KR (1) | KR20090034969A (enExample) |
| CN (1) | CN101511780A (enExample) |
| AR (1) | AR062217A1 (enExample) |
| AU (1) | AU2007280604A1 (enExample) |
| BR (1) | BRPI0715084A2 (enExample) |
| CA (1) | CA2658797A1 (enExample) |
| EA (1) | EA200970170A1 (enExample) |
| IL (1) | IL196594A0 (enExample) |
| MX (1) | MX2009001104A (enExample) |
| SG (1) | SG174032A1 (enExample) |
| TW (1) | TW200815326A (enExample) |
| WO (1) | WO2008015081A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8410150B2 (en) | 2007-03-09 | 2013-04-02 | University Health Network | Inhibitors of carnitine palmitoyltransferase and treating cancer |
| US8680282B2 (en) | 2007-08-01 | 2014-03-25 | University Health Network | Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| MX2010008196A (es) * | 2008-04-29 | 2010-08-11 | Hoffmann La Roche | Derivados de acido 4-dimetilaminobutirico. |
| WO2009132979A1 (en) * | 2008-04-29 | 2009-11-05 | F. Hoffmann-La Roche Ag | 4-trimethylammonio-butyrates as cpt2 inhibitors |
| US8957032B2 (en) * | 2008-05-06 | 2015-02-17 | Alba Therapeutics Corporation | Inhibition of gliadin peptides |
| KR20110044209A (ko) * | 2008-06-24 | 2011-04-28 | 다라 바이오싸이언시즈, 아이엔씨. | 효소 억제제 및 그의 용도 |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0127098B1 (en) | 1983-05-25 | 1989-02-08 | Takeda Chemical Industries, Ltd. | Derivatives of beta-amino-gamma-trimethylammonio-butyrate, their production and use |
| HUT65327A (en) | 1992-06-11 | 1994-05-02 | Sandoz Ag | Process for producing phosphinyloxy-propyl-ammonium inner sact derwatives ang pharmateutical preparations containing them |
| IT1299266B1 (it) | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
-
2007
- 2007-07-10 JP JP2009522200A patent/JP2009545549A/ja not_active Withdrawn
- 2007-07-10 AU AU2007280604A patent/AU2007280604A1/en not_active Abandoned
- 2007-07-10 WO PCT/EP2007/057030 patent/WO2008015081A1/en not_active Ceased
- 2007-07-10 CA CA002658797A patent/CA2658797A1/en not_active Abandoned
- 2007-07-10 MX MX2009001104A patent/MX2009001104A/es not_active Application Discontinuation
- 2007-07-10 EA EA200970170A patent/EA200970170A1/ru unknown
- 2007-07-10 SG SG2011055696A patent/SG174032A1/en unknown
- 2007-07-10 EP EP07787305A patent/EP2046734A1/en not_active Withdrawn
- 2007-07-10 US US12/374,774 patent/US20090312286A1/en not_active Abandoned
- 2007-07-10 BR BRPI0715084-9A patent/BRPI0715084A2/pt not_active IP Right Cessation
- 2007-07-10 KR KR1020097002824A patent/KR20090034969A/ko not_active Withdrawn
- 2007-07-10 CN CNA200780032448XA patent/CN101511780A/zh active Pending
- 2007-08-02 TW TW096128440A patent/TW200815326A/zh unknown
- 2007-08-06 AR ARP070103457A patent/AR062217A1/es not_active Application Discontinuation
-
2009
- 2009-01-19 IL IL196594A patent/IL196594A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009545549A5 (enExample) | ||
| US10315993B2 (en) | Synergistic compositions | |
| DE60216094T2 (de) | Modulatoren der peroxisom-proliferator-aktivierten rezeptoren (ppar) | |
| JP4607318B2 (ja) | 対称および非対称置換ジフェニル尿素を用いるｒａｆキナーゼの阻害 | |
| DE60005973T2 (de) | Biaryl-oxa(thia)zolderivate und ihre verwendung als ppars modulatoren | |
| US9561201B2 (en) | Therapeutic compounds | |
| HUP0201858A2 (en) | Thiazole and oxazole derivatives and their pharmaceutical use | |
| CN1069312C (zh) | 取代的亚胺基磺酰胺、其制法、用途、和含有它们的药物 | |
| JP6238460B2 (ja) | 脂質異常症治療剤 | |
| HUP0203532A2 (hu) | HPPAR-alfa aktivátor szubsztituált oxazol- és tiazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0400056A2 (hu) | Tiazol- vagy oxazolszármazékok, melyek szív-érrendszeri betegségek gyógyítására alkalmazhatók és a vegyületeket tartalmazó gyógyszerkészítmények | |
| JP2012506852A5 (enExample) | ||
| HUP0103376A2 (hu) | Új 3-aril-2-hidroxi-propinsav-származék, ezt tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk | |
| WO2001025190A1 (en) | Novel diarylamide derivatives and use thereof as medicines | |
| IL287159B1 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| WO2007081091A1 (en) | Rhodandse derivarives, a process for the preparation thereof and pharmaceutical composition containing the same | |
| JPH08823B2 (ja) | 血糖低下性チアゾリジンジオンとその中間体 | |
| HUP0400043A2 (hu) | HPPAR-alfa receptor aktiváló hatású oxazol/tiazol-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| JP2005526834A (ja) | インダン酢酸誘導体および薬剤としてのそれらの使用 | |
| HUP0400117A2 (hu) | A 2-metil-2-[4-({[4-metil-2-(4-trifluormetil-fenil)-tiazol-5-karbonil]-amino}-metil)-fenoxi]-propionsav polimorf formái, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
| CA2590575A1 (en) | 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands | |
| JP4209684B2 (ja) | 新しい化合物 | |
| CN108440440B (zh) | 一种含萘环的1,2,4-噁二唑-肉桂酰哌嗪型化合物及其制法和用途 | |
| WO2011002012A1 (ja) | Sglt1阻害薬とインスリン抵抗性改善薬を組み合わせてなる医薬 | |
| KR100827353B1 (ko) | 2-에톡시프로피온산 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 당뇨병 예방 및 치료제 |